申请人:SmithKline Beecham p.l.c.
公开号:US05827865A1
公开(公告)日:1998-10-27
Compounds of Formula (I) A.sup.1 --X--(CH.sub.2).sub.n --O--A.sup.2 --A.sup.3 --Y.R.sup.2(I) or a tautomeric form thereof and/or a pharmaceutically acceptable salt thereof, and/or a pharmaceutically acceptable solvate thereof, wherein A.sup.1, A.sup.2, A.sup.3, R.sup.2, X, Y and n are as defined herein; a pharmaceutical composition comprising such a compound and the use of such a compound or composition in medicine as described.
化合物的公式(I) A.sup.1 --X--(CH.sub.2).sub.n --O--A.sup.2 --A.sup.3 --Y.R.sup.2(I)或其互变异构体和/或其药学上可接受的盐,和/或其药学上可接受的溶剂,其中A.sup.1,A.sup.2,A.sup.3,R.sup.2,X,Y和n如本文所定义;包括这种化合物的药物组合物以及这种化合物或组合物在药学中的用途。